Low expression of DNMT3A and positive N-status were associated with disease-specific mortality in patients with advanced stage laryngeal squamous cell carcinoma primarily treated with radiotherapy. This evidence concerns the gene DNMT3A and laryngeal squamous cell carcinoma.